Who Buys Ciprofloxacin from India — 3081 Importers Behind a $301.1M Market
India's ciprofloxacin import market is served by 3081 active buyers who collectively imported $301.1M across 14,146 shipments. DR REDDYS LABORATORIES INC (UNITED STATES) leads with a 10.3% market share, followed by DR, REDDYS LABORATORIES, INC and NORTHSTAR DISTRIBUTION CENTRE 8912. The top 5 buyers together control 29.9% of total import value, reflecting a moderately competitive buyer landscape.
Top Ciprofloxacin Importers — Ranked by Import Value
DR REDDYS LABORATORIES INC (UNITED STATES) is the leading ciprofloxacin importer from India, holding a 10.3% share of the $301.1M market across 14,146 shipments from 3081 buyers. The top 5 buyers — DR REDDYS LABORATORIES INC (UNITED STATES), DR, REDDYS LABORATORIES, INC (UNITED STATES), NORTHSTAR DISTRIBUTION CENTRE 8912 (UNITED STATES), DELTA IMPORT - EXPORT MEDICAL CO, (VIETNAM), DR.REDDY'S LABORATORIES,INC (UNITED STATES) — collectively control 29.9% of total import value.
Top Ciprofloxacin Buyers & Importers
Ranked by import value · 3081 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | DR REDDYS LABORATORIES INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN 500 MG TABLETS 10X10SCIPROFLOXACIN TABLETS USP 250MG(12000 X | $30.9M | 5 | 10.3% |
| 2 | DR, REDDYS LABORATORIES, INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $23.4M | 5 | 7.8% |
| 3 | NORTHSTAR DISTRIBUTION CENTRE 8912UNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $13.4M | 5 | 4.4% |
| 4 | DELTA IMPORT - EXPORT MEDICAL CO,VIETNAM CIPROFLOXACIN 500 MG TABLETS 10X10SAXOFLOX-500 (CIPROFLOXACIN TABLETS BP 50MICROLUSS (CIPROFLOXACIN TABLETS USP 500 | $11.9M | 5 | 4.0% |
| 5 | DR.REDDY'S LABORATORIES,INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $10.5M | 5 | 3.5% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES,INC.UNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN AND DEXAMETHASONE STERILE OTIC SUSPENSION USPCIPROFLOXACIN TABLETS 500MG (WHITE,ELONG | $9.3M | 5 | 3.1% |
| 7 | AO RANBAXYRUSSIA CIPROFLOXACIN 500 MG TABLETS 10X10SCIPROFLOXACIN TABLETS BP (3AXOFLOX-500 (CIPROFLOXACIN TABLETS BP 50 | $8.3M | 5 | 2.7% |
| 8 | LLC SENTISS RUSRUSSIA CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN TABLETS USP 250MG(12000 XCIPROBID 500MG TABS | $6.6M | 5 | 2.2% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN AND DEXAMETHASONE STERILE OTIC SUSPENSION USPCIPROFLOXACIN TABLETS 500MG (WHITE,ELONG | $6.1M | 5 | 2.0% |
| 10 | FIDSON HEALTHCARE PLCNIGERIA CIPROTAB 500-CIPROFLOXACIN TABLETS USP 5CIPROTAB 500- CIPROFLOXACIN TABLETS USP500 MG PACK: 1X10SCIPROTAB 500- CIPROFLOXACIN TABLETS USP | $5.5M | 5 | 1.8% |
| 11 | OKAR AGENCYSIERRA LEONE | $5.1M | 5 | 1.7% |
| 12 | SUN PHARMACEUTICAL INDUSTRIES INC.UNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN AND DEXAMETHASONE STERILE OTIC SUSPENSION USPCIPROFLOXACIN TABLETS 500MG (WHITE,ELONG | $4.2M | 5 | 1.4% |
| 13 | LEADING PHARMAUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $4.2M | 5 | 1.4% |
| 14 | DR REDDYS LABORATORIES,INCUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN 500 MG TABLETS 10X10SCIPROFLOXACIN TABLETS USP 250MG(12000 X | $4.1M | 5 | 1.4% |
| 15 | AUROLOGISTICS LLC (AUROBINDO PHARMAUNITED STATES CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $3.4M | 5 | 1.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Ciprofloxacin — and from which countries?
Flow of Ciprofloxacin exports from India: each country's share and the named importers behind the numbers
Ciprofloxacin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $127.3M through 264 shipments. This represents a market share of 42.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• DR REDDYS LABORATORIES INC - $30.9M (24.3% of country's total business)
• DR, REDDYS LABORATORIES, INC - $23.4M (18.4% of country's total business)
• NORTHSTAR DISTRIBUTION CENTRE 8912 - $13.4M (10.5% of country's total business)
• DR.REDDY'S LABORATORIES,INC - $10.5M (8.2% of country's total business)
• SUN PHARMACEUTICAL INDUSTRIES,INC. - $9.3M (7.3% of country's total business)
• Rest of United States's importers - $39.8M (31.3% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $482.2K, indicating premium pricing strategy compared to the market average of $21.3K.
United States is a key market for Ciprofloxacin imports, representing 42.3% of total trade value.
2Russia
Russia emerges as the second largest importing country, achieving a total trade value of $21.2M through 164 shipments. This represents a market share of 7.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• AO RANBAXY - $8.3M (38.9% of country's total business)
• LLC SENTISS RUS - $6.6M (31.0% of country's total business)
• AO "RANBAXY" - $2.4M (11.3% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $129.5K, indicating premium pricing strategy compared to the market average of $21.3K.
Russia is a key market for Ciprofloxacin imports, representing 7.1% of total trade value.
3Vietnam
Vietnam emerges as the third largest importing country, achieving a total trade value of $20.8M through 4 shipments. This represents a market share of 6.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Vietnam has a diverse importer base, with their top importers including:
• DELTA IMPORT - EXPORT MEDICAL CO, - $11.9M (57.3% of country's total business)
Key Insight: Vietnam demonstrates strong market positioning with an average shipment value of $5.2M, indicating premium pricing strategy compared to the market average of $21.3K.
Vietnam is a key market for Ciprofloxacin imports, representing 6.9% of total trade value.
4Nigeria
Nigeria emerges as the fourth largest importing country, achieving a total trade value of $18.4M through 63 shipments. This represents a market share of 6.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• FIDSON HEALTHCARE PLC - $5.5M (30.0% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $292.2K, indicating premium pricing strategy compared to the market average of $21.3K.
Nigeria is a key market for Ciprofloxacin imports, representing 6.1% of total trade value.
5Ethiopia
Ethiopia emerges as the fifth largest importing country, achieving a total trade value of $6.6M through 0 shipments. This represents a market share of 2.2% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Ethiopia demonstrates strong market positioning with an average shipment value of $6.6M, indicating premium pricing strategy compared to the market average of $21.3K.
Ethiopia is a key market for Ciprofloxacin imports, representing 2.2% of total trade value.
Buyer Segment Analysis
TransData Nexus Ciprofloxacin buyer market intelligence
1Buyer Segment Analysis
The importers of Ciprofloxacin from India can be categorized into several key segments:
1. Pharmaceutical Companies: Entities such as Dr. Reddy's Laboratories Inc. and Sun Pharmaceutical Industries Inc. in the United States fall into this category. These companies import Ciprofloxacin for direct distribution and sale under their brand names. Their purchasing behavior is characterized by large, consistent orders to maintain a steady supply chain and meet market demand.
2. Distributors: Companies like Northstar Distribution Centre 8912 in the United States serve as intermediaries, purchasing Ciprofloxacin in bulk and supplying it to various healthcare providers, pharmacies, and retailers. Their order patterns are typically large and regular, aligning with the needs of their diverse client base.
3. Government Procurement Agencies: Entities such as Delta Import - Export Medical Co. in Vietnam and Fidson Healthcare Plc in Nigeria often participate in government tenders to supply Ciprofloxacin to public health facilities. Their purchasing behavior is influenced by government procurement cycles, leading to large, periodic orders based on tender awards.
4. Hospital Groups and Healthcare Providers: Organizations like AO Ranbaxy and LLC Sentiss Rus in Russia may represent hospital groups or large healthcare providers that import Ciprofloxacin directly for use within their facilities. Their order patterns are typically based on internal consumption rates, resulting in moderate to large orders placed at regular intervals.
5. Contract Manufacturers: Some buyers may act as contract manufacturers, importing Ciprofloxacin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their purchasing behavior is driven by production schedules and client demands, leading to variable order sizes and frequencies.
Country-Specific Import Regulations
TransData Nexus Ciprofloxacin buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Ciprofloxacin in the top five importing countries is crucial for market entry and compliance:
1. United States:
2. Russia:
3. Vietnam:
4. Nigeria:
5. Ethiopia:
Demand Drivers & Market Opportunity
TransData Nexus Ciprofloxacin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Ciprofloxacin in importing countries is driven by several factors:
1. Disease Prevalence: Ciprofloxacin is a broad-spectrum antibiotic used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, and gastrointestinal infections. High prevalence rates of these conditions in many countries contribute to sustained demand.
2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the inclusion of Ciprofloxacin in national essential medicines lists ensures its availability in public health facilities.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines like Ciprofloxacin to meet the healthcare needs of the population.
4. WHO Essential Medicines List Procurement: Ciprofloxacin's inclusion in the World Health Organization's Essential Medicines List underscores its importance in treating priority health conditions, prompting countries to prioritize its procurement.
5. Tender-Based Purchasing: Many governments and international organizations utilize tendering processes to procure medicines, ensuring competitive pricing and consistent supply. This approach is common in countries like Nigeria and Vietnam, where government tenders significantly influence procurement patterns.
With 3,081 buyers across 180 countries, the global market for Ciprofloxacin presents substantial opportunities. Understanding the specific demand drivers and regulatory landscapes in each country is essential for strategic market entry and sustained growth.
Common Questions — Ciprofloxacin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest ciprofloxacin buyer importing from India?
Based on import volume and value, DR REDDYS LABORATORIES INC (UNITED STATES) leads with $30.9M in imports and a 10.3% market share — the highest of any single ciprofloxacin importer. DR, REDDYS LABORATORIES, INC (UNITED STATES) and NORTHSTAR DISTRIBUTION CENTRE 8912 (UNITED STATES) are the next largest buyers.
QHow many companies buy ciprofloxacin from India?
There are 3081 active ciprofloxacin buyers importing from India, with a combined market of $301.1M across 14,146 shipments to 180 countries. The top 5 buyers hold 29.9% of total import value, while the remaining 3076 buyers handle the other 70.1%.
QWhich countries import the most ciprofloxacin from India?
The top importing countries for ciprofloxacin from India are United States (42.3%), Russia (7.1%), Vietnam (6.9%), Nigeria (6.1%), Ethiopia (2.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of ciprofloxacin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for ciprofloxacin from India?
The average import transaction value for ciprofloxacin from India is $21.3K, with an average unit price of $14.17 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Ciprofloxacin buyer market intelligence
1Buyer Segment Analysis
The importers of Ciprofloxacin from India can be categorized into several key segments:
1. Pharmaceutical Companies: Entities such as Dr. Reddy's Laboratories Inc. and Sun Pharmaceutical Industries Inc. in the United States fall into this category. These companies import Ciprofloxacin for direct distribution and sale under their brand names. Their purchasing behavior is characterized by large, consistent orders to maintain a steady supply chain and meet market demand.
2. Distributors: Companies like Northstar Distribution Centre 8912 in the United States serve as intermediaries, purchasing Ciprofloxacin in bulk and supplying it to various healthcare providers, pharmacies, and retailers. Their order patterns are typically large and regular, aligning with the needs of their diverse client base.
3. Government Procurement Agencies: Entities such as Delta Import - Export Medical Co. in Vietnam and Fidson Healthcare Plc in Nigeria often participate in government tenders to supply Ciprofloxacin to public health facilities. Their purchasing behavior is influenced by government procurement cycles, leading to large, periodic orders based on tender awards.
4. Hospital Groups and Healthcare Providers: Organizations like AO Ranbaxy and LLC Sentiss Rus in Russia may represent hospital groups or large healthcare providers that import Ciprofloxacin directly for use within their facilities. Their order patterns are typically based on internal consumption rates, resulting in moderate to large orders placed at regular intervals.
5. Contract Manufacturers: Some buyers may act as contract manufacturers, importing Ciprofloxacin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their purchasing behavior is driven by production schedules and client demands, leading to variable order sizes and frequencies.
Country-Specific Import Regulations
TransData Nexus Ciprofloxacin buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Ciprofloxacin in the top five importing countries is crucial for market entry and compliance:
1. United States:
2. Russia:
3. Vietnam:
4. Nigeria:
5. Ethiopia:
Demand Drivers & Market Opportunity
TransData Nexus Ciprofloxacin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Ciprofloxacin in importing countries is driven by several factors:
1. Disease Prevalence: Ciprofloxacin is a broad-spectrum antibiotic used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, and gastrointestinal infections. High prevalence rates of these conditions in many countries contribute to sustained demand.
2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the inclusion of Ciprofloxacin in national essential medicines lists ensures its availability in public health facilities.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines like Ciprofloxacin to meet the healthcare needs of the population.
4. WHO Essential Medicines List Procurement: Ciprofloxacin's inclusion in the World Health Organization's Essential Medicines List underscores its importance in treating priority health conditions, prompting countries to prioritize its procurement.
5. Tender-Based Purchasing: Many governments and international organizations utilize tendering processes to procure medicines, ensuring competitive pricing and consistent supply. This approach is common in countries like Nigeria and Vietnam, where government tenders significantly influence procurement patterns.
With 3,081 buyers across 180 countries, the global market for Ciprofloxacin presents substantial opportunities. Understanding the specific demand drivers and regulatory landscapes in each country is essential for strategic market entry and sustained growth.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 3081 global importers of Ciprofloxacin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 14,146 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 180 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
14,146 Verified Shipments
3081 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists